TSLP and gastroenteritis: By promoting the secretion of thymic stromal lymphopoietin, epidermal growth factor, IL-10, IL-25, and transforming growth factor-β1 by intestinal epithelial cells, Gal1 can inhibit experimental intestinal inflammation [16].